Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



Risk of Distant Metastasis in Parathyroid Carcinoma and Its Effect on Survival: A Retrospective Review from a High-Volume Center
Indexado
WoS WOS:000485315800030
Scopus SCOPUS_ID:85066144064
DOI 10.1245/S10434-019-07451-3
Año 2019
Tipo revisión

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



Background Development of distant metastases (DM) is associated with markedly decreased survival in parathyroid carcinoma (PC). We sought to identify factors associated with development of DM and to quantify the effect that development of DM had on overall survival (OS). Methods Patients with surgically resected local/regional PC treated or surveilled at a tertiary-referral cancer hospital from 1980 to 2017 were included. We assessed the association between biochemical and clinicopathologic factors (preoperative parathyroid hormone (PTH) levels, sex, race, age, preoperative serum calcium levels, serum calcium levels at 6 months postop, tumor size, and extent of resection) with the development of DM. We also assessed the effect of development of DM on OS. Results Seventy-five patients with PC were assessed; 17 (22.7%) developed DM at a median follow-up of 77 months. The cumulative incidence of DM in the cohort was 20, 30, and 38% at 5, 10, and 20 years respectively. Tumor size > 3.2 cm based on recursive partitioning analysis was the only significant predictor for development of DM (hazard ratio (HR) = 3.51; 95% confidence interval [CI] 1.04-11.91; p = 0.04). Median OS for the entire cohort was 17 years compared with 40 months for the cohort who developed DM. The HR for death after distant metastasis was 9.6 (95% CI 4.2-22.3; p < 0.0001). Conclusions Development of distant metastasis during surveillance is associated with decreased OS, including late recurrences. Primary tumor size should be considered in future interval surveillance and development of treatment algorithms.

Revista



Revista ISSN
Annals Of Surgical Oncology 1068-9265

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Surgery
Oncology
Scopus
Sin Disciplinas
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Asare, Elliot A. Hombre Univ Texas MD Anderson Canc Ctr - Estados Unidos
University of Texas MD Anderson Cancer Center - Estados Unidos
The University of Texas MD Anderson Cancer Center - Estados Unidos
2 SILVA-FIGUEROA, ANGELICA MARIA Mujer Universidad Finis Terrae - Chile
Complejo Asistencial Barros Luco Trudeau - Chile
Hospital Barros Luco Trudeau - Chile
Hosp Barros Luco - Chile
3 Hess, Kenneth R. Hombre Univ Texas MD Anderson Canc Ctr - Estados Unidos
University of Texas MD Anderson Cancer Center - Estados Unidos
The University of Texas MD Anderson Cancer Center - Estados Unidos
4 Busaidy, Naifa - Univ Texas MD Anderson Canc Ctr - Estados Unidos
University of Texas MD Anderson Cancer Center - Estados Unidos
The University of Texas MD Anderson Cancer Center - Estados Unidos
5 Graham, P. H. Hombre Univ Texas MD Anderson Canc Ctr - Estados Unidos
University of Texas MD Anderson Cancer Center - Estados Unidos
The University of Texas MD Anderson Cancer Center - Estados Unidos
6 Grubbs, Elizabeth G. Mujer Univ Texas MD Anderson Canc Ctr - Estados Unidos
University of Texas MD Anderson Cancer Center - Estados Unidos
The University of Texas MD Anderson Cancer Center - Estados Unidos
7 Lee, Jeffrey E. Hombre Univ Texas MD Anderson Canc Ctr - Estados Unidos
University of Texas MD Anderson Cancer Center - Estados Unidos
The University of Texas MD Anderson Cancer Center - Estados Unidos
8 Williams, Michelle D. Mujer Univ Texas MD Anderson Canc Ctr - Estados Unidos
University of Texas MD Anderson Cancer Center - Estados Unidos
The University of Texas MD Anderson Cancer Center - Estados Unidos
9 Perrier, Nancy D. Mujer Univ Texas MD Anderson Canc Ctr - Estados Unidos
University of Texas MD Anderson Cancer Center - Estados Unidos
The University of Texas MD Anderson Cancer Center - Estados Unidos

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
Sin Información

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
Sin Información

Muestra la fuente de financiamiento declarada en la publicación.